Monday, March 8, 2021
Dr Vladislav Sandler, CEO & Co-Founder of Hemogenyx Pharmaceuticals (HEMO.L) Interview
Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, is pleased to annou...